comparemela.com

தன்னாட்சி நிறுவனம் ஆஃப் துறை உயிரி தொழில்நுட்பவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DBT-NII receives Trademark for India s first indigenous tumour antigen SPAG9

New Delhi [India], June 4 (ANI): India's first indigenous tumour antigen, SPAG9 discovered by Dr Anil Suri, head of Cancer Research Program at Delhi based National Institute of Immunology (NII), an Autonomous Institute of Department of Biotechnology (DBT), in 1998 has received the trademark ASPAGNII, the Ministry of Science and Technology informed on Friday.

NII receives Trademark for India s first indigenous tumour antigen SPAG9

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.